Literature DB >> 19525516

Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults.

Jesús Oteo1, Oscar Cuevas, Inmaculada López-Rodríguez, Ana Banderas-Florido, Ana Vindel, María Pérez-Vázquez, Verónica Bautista, Margarita Arroyo, Juan García-Caballero, Pilar Marín-Casanova, Rubén González-Sanz, Víctor Fuentes-Gómez, Salvador Oña-Compán, Silvia García-Cobos, José Campos.   

Abstract

OBJECTIVES: To characterize the population structure and resistance mechanisms of Klebsiella pneumoniae isolates that are highly resistant to third-generation cephalosporins, collected from five Spanish hospitals.
METHODS: A total of 162 K. pneumoniae isolates from five hospitals located in three geographical areas of Spain were characterized. The number of isolates from each hospital ranged from 3 to 82. The genetic relationship between isolates was established by PFGE and multilocus sequence typing (MLST). bla(ESBL) types and other antibiotic resistance genes were analysed by PCR and sequencing. Plasmids were classified according to their incompatibility group by a PCR-based replicon-typing scheme.
RESULTS: All 162 isolates carried the bla(CTX-15) gene. Fifty-eight isolates (35.8%) caused clinical infections and 104 (64.2%) were colonizers. Sixty-nine (42.6%) isolates were collected from newborns and 93 (57.4%) from adults. Using PGFE, the 162 isolates were grouped into seven clusters that were further identified as members of the MLST types 1, 11, 14, 17, 20, 35 and 36. Two hospitals each had two different clones and the remaining three hospitals had a single CTX-M-15-producing K. pneumoniae clone. All clones carried different antibiotic resistance genes, including bla(OXA-1), aac(3)-IIa, aac(6')-Ib-cr, qnrS1 and qnrB. In four of the seven (57.1%) clones the bla(CTX-M-15) gene was transferred by conjugation; in all cases plasmids of the incompatibility group IncF were identified by PCR.
CONCLUSIONS: This study shows that multiresistant K. pneumoniae producing CTX-M-15 of MLST types 1, 11, 14, 17, 20, 35 and 36 are spreading as pathogens and colonizers among newborns and adult patients in Spain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525516     DOI: 10.1093/jac/dkp211

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010.

Authors:  Mohammed O Abdelaziz; Celestino Bonura; Aurora Aleo; Ramadan A El-Domany; Teresa Fasciana; Caterina Mammina
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

2.  Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features.

Authors:  C Ruiz de Alegría; J Rodríguez-Baño; M E Cano; J R Hernández-Bello; J Calvo; E Román; M A Díaz; A Pascual; L Martínez-Martínez
Journal:  J Clin Microbiol       Date:  2010-12-29       Impact factor: 5.948

3.  Emergence of an NDM-5-Producing Hypervirulent Klebsiella pneumoniae Sequence Type 35 Strain with Chromosomal Integration of an Integrative and Conjugative Element, ICEKp1.

Authors:  Zhen Shen; Qianqian Gao; Juanxiu Qin; Yao Liu; Min Li
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

Review 4.  Plasmid-mediated quinolone resistance.

Authors:  George A Jacoby; Jacob Strahilevitz; David C Hooper
Journal:  Microbiol Spectr       Date:  2014-10

5.  A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.

Authors:  Amos Adler; Svetlana Paikin; Yelena Sterlin; Josef Glick; Rotem Edgar; Rima Aronov; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

6.  Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil.

Authors:  Leonardo Neves Andrade; Tânia Curiao; Joseane Cristina Ferreira; Juliana Mucedola Longo; Eduardo Carneiro Clímaco; Roberto Martinez; Fernando Bellissimo-Rodrigues; Aníbal Basile-Filho; Marco Antônio Evaristo; Pedro F Del Peloso; Vanessa Bley Ribeiro; Afonso Luis Barth; Milena Cristina Paula; Fernando Baquero; Rafael Cantón; Ana Lúcia da Costa Darini; Teresa M Coque
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

7.  The Carbapenemase-Producing Klebsiella pneumoniae Population Is Distinct and More Clonal than the Carbapenem-Susceptible Population.

Authors:  Andrés Esteban-Cantos; Belén Aracil; Verónica Bautista; Adriana Ortega; Noelia Lara; David Saez; Sara Fernández-Romero; María Pérez-Vázquez; Ferran Navarro; Hajo Grundmann; José Campos; Jesús Oteo
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

8.  Diversity of clonal types of Klebsiella pneumoniae causing infections in intensive care neonatal patients in a large urban setting.

Authors:  Livia Helena Justo-da-Silva; Andrea Nunes De-Azeredo; Arnaldo Costa Bueno; Lara Feital Montezzi; Maria Beatriz Gerardin Poirot Leobons; Maria Silvana Alves; Patrícia de Souza Inhaquite; Rosana Rangel Santos; Valéria Brígido Carvalho Girão; Antônio José Ledo Alves da Cunha; Carmem Lucia Pessoa-Silva; Renata Cristina Picão; Cristina Barroso Hofer; Guilherme Santoro-Lopes; Lee Woodland Riley; Beatriz Meurer Moreira
Journal:  Braz J Microbiol       Date:  2019-08-10       Impact factor: 2.476

9.  Molecular epidemiology of colonizing and disease-causing Klebsiella pneumoniae in paediatric patients.

Authors:  Malaika L Little; Xuan Qin; Danielle M Zerr; Scott J Weissman
Journal:  J Med Microbiol       Date:  2014-01-25       Impact factor: 2.472

Review 10.  Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance.

Authors:  David C Hooper; George A Jacoby
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.